Through the new framework, WHO and AMA will coordinate efforts to streamline approval processes, enhance post-market surveillance, and build regulatory workforce capacity.
The partnership builds on Africa CDC’s recent efforts to accelerate the deployment of community health workers across the continent through collaborations with regional partners.
Yuhan operates two API manufacturing facilities in South Korea and has reported steady international growth, with overseas sales increasing 21% in the first quarter.
The acquisition reflects a long-term strategic collaboration between the two companies, with Artivion already serving as the exclusive distributor of NEXUS across Europe, the Middle East, and Africa since 2019.
Owen Mumford brings established expertise in device design, precision moulding, and medical device assembly, which will now be integrated with Embecta’s commercial infrastructure and large-scale manufacturing capabilities.
The acquisition follows Stryker’s earlier move into the vascular intervention market through its approximately US$4.9 billion purchase of Inari Medical in 2025.
Under the partnership, IVI will collaborate closely with institutions such as the Kenya Medical Research Institute, the Kenya BioVax Institute, and the Pharmacy and Poisons Board to support vaccine development, manufacturing, and regulatory strengthening.
Under the partnership, ITWORX Education will implement Avicenna, its advanced Health Information System (HIS) and Enterprise Resource Planning (ERP) platform, across Global Medical City’s hospital ecosystem.
Neuralink’s clinical programme has recorded notable early milestones, including reports that its first human participant successfully operated a computer and typed using neural signals alone.
This four-year project seeks to fortify microbiology laboratory systems and expand antimicrobial resistance surveillance across the continent using an integrated One Health approach.